NCT04310033 (QdV-ONCOREA) is a clinical trial of Questionnaires in Solid Tumor, Adult, sponsored by University Hospital, Grenoble.

Who is sponsoring NCT04310033?

NCT04310033 is sponsored by University Hospital, Grenoble.

What drugs are being tested in NCT04310033?

Interventions in NCT04310033: Questionnaires.

What condition does NCT04310033 study?

NCT04310033 studies Solid Tumor, Adult.

Is NCT04310033 still recruiting?

NCT04310033 is currently completed. Last updated 1 September 2021.

Last reviewed 2021-09-01 · How we verify

NCT04310033: QdV-ONCOREA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of ICU on the Quality of Life in Cancer Patients

Completed Last updated 1 September 2021

What this trial tests

trial testing Questionnaires in Solid Tumor, Adult in 60 participants. Completed in 13 July 2021.

Timeline

24 February 2020

Primary endpoint
13 July 2021

13 July 2021

Quick facts

Lead sponsor	University Hospital, Grenoble
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	24 February 2020
Primary completion	13 July 2021
Estimated completion	13 July 2021
Sites	1 location across France

Drugs / interventions tested

Questionnaires

Conditions studied

Solid Tumor, Adult — all drugs for Solid Tumor, Adult →

Sponsor

University Hospital, Grenoble

Who can join

18 and older, any sex, with Solid Tumor, Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, prospective, monocentric, case-control study. Investigators aim to compare the quality of life and oncological treatment strategy in cancer patients admitted or not in ICU.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Quality of life of patients with solid malignancies at 3 months after unplanned admission in the intensive care unit: A prospective case-control study.
Toffart AC, M'Sallaoui W, Jerusalem S, Godon A, et al · · 2023 · cited 2× · PMID 36603018 · DOI 10.1371/journal.pone.0280027

Verify or expand the search:

Other recruiting trials for Solid Tumor, Adult

Currently open trials in the same condition.

NCT07139990 — Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) · Phase 1 · recruiting
NCT06398418 — R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients · Phase 1 · recruiting
NCT06682793 — A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumor · Phase 1, PHASE2 · recruiting
NCT07137195 — Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei) · NA · active not recruiting
NCT06714617 — Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · Phase 1 · active not recruiting

Other University Hospital, Grenoble trials

Trials by the same sponsor.

NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04310033 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
Last refreshed: 1 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04310033.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing